OOIR: Observatory of International Research

Papers

(The H4-Index of Current Cardiology Reports is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Promise and Perils of Telehealth in the Current Era	69
Ischemic Cardiomyopathy and Heart Failure After Acute Myocardial Infarction	63
Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19	62
Mechanisms and Treatment of Dyslipidemia in Diabetes	57
Management of Arrhythmias Associated with COVID-19	53
Pericardial Diseases in COVID19: a Contemporary Review	46
Complications Following MitraClip Implantation	44
Cardiac Rehabilitation: Under-Utilized Globally	44
Familial Hypercholesterolemia: Global Burden and Approaches	43
Racial and Ethnic Disparities in Hypertension: Barriers and Opportunities to Improve Blood Pressure Control	42
Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors	41
18F-FDG PET/CT in Infective Endocarditis: Indications and Approaches for Standardization	41
State-of-the-Art of Endomyocardial Biopsy on Acute Myocarditis and Chronic Inflammatory Cardiomyopathy	40
Wnt Signaling in Heart Development and Regeneration	38
Home Monitoring of Cardiac Devices in the Era of COVID-19	38
Immunotherapy-Associated Cardiotoxicity of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy: Diagnostic and Management Challenges and Strategies	36
Remote monitoring and telemedicine in heart failure: implementation and benefits	35
5-FU Cardiotoxicity: Vasospasm, Myocarditis, and Sudden Death	35
Improving Quality of Life in Heart Failure	34
Associations of Glycemic Index and Glycemic Load with Cardiovascular Disease: Updated Evidence from Meta-analysis and Cohort Studies	34
Loneliness and Risk for Cardiovascular Disease: Mechanisms and Future Directions	32
Metabolic Syndrome and Cognitive Function	30
COVID-19 and Cardiovascular Disease: a Global Perspective	29
How Much Lowering of Blood Pressure Is Required to Prevent Cardiovascular Disease in Patients With and Without Previous Cardiovascular Disease?	29
Cardiac Rehab in the COVID Era and Beyond: mHealth and Other Novel Opportunities	26

Comprehensive Care Models for Cardiometabolic Disease	25
Epidemiology of Type 1 Diabetes	25